(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 20.66% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.33%.
Evolent Health's revenue in 2026 is $1,876,229,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $280,435,505,056, with the lowest EVH revenue forecast at $263,913,031,032, and the highest EVH revenue forecast at $301,981,704,290. On average, 15 Wall Street analysts forecast EVH's revenue for 2027 to be $324,867,563,580, with the lowest EVH revenue forecast at $290,706,232,152, and the highest EVH revenue forecast at $375,774,645,708.
In 2028, EVH is forecast to generate $367,401,770,358 in revenue, with the lowest revenue forecast at $318,057,624,962 and the highest revenue forecast at $421,992,917,640.